लोड हो रहा है...
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
BACKGROUND: Brexpiprazole and cariprazine are the latest US Food and Drug Administration approved atypical antipsychotics available in the United States. Both function as partial agonists of the dopamine-2 receptor (D(2)R), a mechanism of action shared with aripiprazole. However, all three differ in...
में बचाया:
| में प्रकाशित: | Ther Adv Psychopharmacol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228714/ https://ncbi.nlm.nih.gov/pubmed/28101322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125316672136 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|